Manuscripts
Showing 1572 manuscripts.
The prevalence and incidence of neurocognitive impairment in the HAART era
Citation
Kevin R. Robertson, Marlene Smurzynski, Thomas D. Parsons, Kunling Wu, Ronald J. Bosch, Julia (Wei) Wu, Justin C. McArthur, Ann C. Collier, Scott Evans, Ronald J. Ellis. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007. 21: 1915-21.Year
2007
Journal
AIDS
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s study team
Citation
Francesca Aweeka, Minhee Kang, Ji Young Yu, Patricia S. Lizak, Beverly L. Alston-Smith, Raymond T. Chung. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s study team. HIV Medicine. 2007. 8: 288-94.Year
2007
Journal
HIV Medicine
Virologic response to potent antiretroviral therapy and modeling of HIV dynamics in early pediatric infection.
Citation
Paul Palumbo, Hulin Wu, Ellen Gould Chadwick, Ping Ruan, Katherine Luzuriaga, John H. Rodman, Ram Yogev. Virologic response to potent antiretroviral therapy and modeling of HIV dynamics in early pediatric infection.. Journal of Infectious Diseases. 2007. 196: 23-29. PMID: 17538879Year
2007
Journal
Journal of Infectious Diseases
Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.
Citation
Patricia M. Flynn, John H. Rodman, Jane C. Lindsey, Brian Robbins, Edmund Capparelli, Katherine M. Knapp, Jose F. Rodriguez, James McNamara, Leslie Serchuck, Barbara E. Heckman, Jaime Martinez. Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.. Antimicrobial Agents and Chemotherapy. 2007. 51: 3516-3522. PMID: 17664328Year
2007
Journal
Antimicrobial Agents and Chemotherapy
Study
P1012
Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.
Citation
Adriana H. Tremoulet, Edmund Capparelli, Pratima K. Patel, Edward P. Acosta, Katherine Luzuriaga, Yvonne J. Bryson, Diane W. Wara, Diane Holland, Mark Mirochnick. Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.. Antimicrobial Agents and Chemotherapy. 2007. 51: 4297 - 7302. PMID: 17893155Year
2007
Journal
Antimicrobial Agents and Chemotherapy
CYP2B6 genetic variants impact the pharmacokinetics of nevirapine and clinical response in HIV-1 infected children receiving HAART.
Citation
Akihiko Saitoh, Elizabeth Sarles, Edmund Capparelli, Francesca Aweeka, Andrea Kovacs, Sandra K. Burchett, Andrew A. Wiznia, Sharon Appelbaum Nachman, Terence Fenton, Stephen A. Spector. CYP2B6 genetic variants impact the pharmacokinetics of nevirapine and clinical response in HIV-1 infected children receiving HAART.. AIDS. 2007. 21: 2191 - 2199. PMID: 18090046Year
2007
Journal
AIDS
Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
Citation
Deborah Persaud, Paul Palumbo, Carrie Ziemniak, Jie (Ellen) Chen, Stuart C. Ray, Michael Hughes, Peter Havens, Murli Purswani, Aditya Gaur, Ellen Gould Chadwick. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.. Journal of Infectious Diseases. 2007. 195: 1402-1410. PMID: 17436219Year
2007
Journal
Journal of Infectious Diseases
Study
P1030
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.
Citation
Adriana Weinberg, Coleen K. Cunningham, Ross E. McKinney, Elaine J. Abrams, John H. Rodman, M. Robert Blum, ChengCheng Hu, Gregory E. Chittick, Paula Britto, Laurie Reynolds, Michael Hughes, Mobeen H. Rathore, Elizabeth (Betsy) Smith, Leslie Serchuck, Alberto A. Ortiz, Patricia M. Flynn, Ram Yogev, Stephen A. Spector, Linda Draper (Marillo), Melissa Scites, Ruth E. Dickover. Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.. Pediatrics. 2007. 120: e416-e423. PMID: 17646352Year
2007
Journal
Pediatrics
Study
P1021
Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.
Citation
Ruth E. Tuomala, Jashvant D. Unadkat, Diane W. Wara, Michael Hughes, Anita A. Mathias, Diane Holland, Mary E. Paul, James D. Connor, Sharon Huang, Bach-Yen Nguyen, Heather D. Watts, Lynne M. Mofenson, Elizabeth (Betsy) Smith, Paul Deutsch, Kathleen A. Kaiser. Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.. Antimicrobial Agents and Chemotherapy. 2007. 51: 783 - 786. PMID: 17158945Year
2007
Journal
Antimicrobial Agents and Chemotherapy
Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).
Citation
Susan A. Fiscus, Andrea Kovacs, Leslie A. Petch, ChengCheng Hu, Andrew A. Wiznia, Lynne M. Mofenson, Ram Yogev, Kenneth McIntosh, Stephen Ira Pelton, Sonia Napravnik, Kenneth Stanley, Sharon Appelbaum Nachman. Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).. AIDS Research & Therapy (online journal). 2007. 4PMID: 17280617Year
2007
Journal
AIDS Research & Therapy (online journal)